Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
SemaThera
511
SemaThera
Technology
Biotechnology
Entreprise en dmarrage dveloppant des inhibiteurs de SEMA 3A Startup company developing SEMA 3A inhibitors / Dr Mike Sapieha HMR, Montreal, Qubec, Canada
Suggest edits
Raised
$2.6M
Follow us
Also headquartered in Montreal
Blockstream
CDPQ
BDC
Element AI
Real Ventures
Transit
Cirque du Soleil
Crew
Unsplash
Coveo
Companies in the same industry
Fountain Medical Development
TMRW Life Sciences
Arpeggio Bio
Ikarovec
Novadip Biosciences
Hualan Biological Engineering
Dynacure
CIMTelligence Systems
Qitan Technology
BioVL
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$2,600,000
Venture capital - 2018
Senju Pharmaceutical
AmorChem
Team Size
1–10
Employees
I work here
Location
Montreal
,
Canada
Headquarters
Explore Montreal
$2,600,000
Venture capital
BetaKit
SemaThera raises $2 million to develop solution for diabetic macular edema
Health
Asia
